Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma

Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma

Identifying the precise moment before the onset of hepatocellular carcinoma (HCC) remains a significant challenge in the medical field. The existing biomarkers fall short of pinpointing the critical point preceding HCC formation. This study aimed to determine the exact tipping point for the transit...

Full description

Bibliographic Details
Main Authors:	Haoyuan Yu, Xijing Yan, Guanxing Chen, Rong Li, Zhou Yang, Zhixing Liang, Linsen Ye, Yunhao Chen, Yang Li
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-03-01
Series:	Biomolecules & Biomedicine
Subjects:	Hepatocellular carcinoma (HCC) Dynamic Network Biomarker (DNB) C1q and tumor necrosis factor (TNF) related 1 (C1QTNF1) diagnosis prognosis
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/10103

Similar Items

Elevated Plasma Levels of C1qTNF1 Protein in Patients with Age-Related Macular Degeneration and Glucose Disturbances
by: Agnieszka Budnik, et al.
Published: (2022-07-01)

C1QTNF3 is Upregulated During Subcutaneous Adipose Tissue Remodeling and Stimulates Macrophage Chemotaxis and M1-Like Polarization
by: Peter Micallef, et al.
Published: (2022-06-01)

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma
by: Jiechuan Qiu, et al.
Published: (2023-07-01)

C1QTNF6 promotes oral squamous cell carcinoma by enhancing proliferation and inhibiting apoptosis
by: Xiaobin Song, et al.
Published: (2021-12-01)

A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapies
by: Brenda D. Moore, et al.
Published: (2023-12-01)

C1q/TNF-Related Proteins 1, 6 and 8 Are Involved in Corneal Epithelial Wound Closure by Targeting Relaxin Receptor RXFP1 In Vitro
by: Hagen Fabian Nicolaus, et al.
Published: (2023-04-01)

C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis
by: Wei Liu, et al.
Published: (2022-03-01)

African swine fever virus infection activates inflammatory responses through downregulation of the anti-inflammatory molecule C1QTNF3
by: Changjie Lv, et al.
Published: (2022-10-01)

C1QTNF6 regulated by miR‐29a-3p promotes proliferation and migration in stage I lung adenocarcinoma
by: Guofu Lin, et al.
Published: (2022-07-01)

Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit
by: Zhangbin Chen, et al.
Published: (2022-03-01)

Autosomal Dominant Gyrate Atrophy-Like Choroidal Dystrophy Revisited: 45 Years Follow-Up and Association with a Novel <i>C1QTNF5</i> Missense Variant
by: Ulrich Kellner, et al.
Published: (2021-02-01)

C1q/TNF‐related protein 4 mediates proliferation and migration of vascular smooth muscle cells during vascular remodelling
by: Jingying Liu, et al.
Published: (2023-05-01)

LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21
by: Xiao L, et al.
Published: (2018-08-01)

Cumulative effects of exercise training and consumption of propolis on managing diabetic dyslipidemia in adult women: a single-blind, randomized, controlled trial with pre–post-intervention assessments
by: Fatemeh Moayedi, et al.
Published: (2023-08-01)

CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation
by: Kai Li, et al.
Published: (2024-04-01)

Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc–ODC1 nexus
by: Haixing Zhang, et al.
Published: (2024-02-01)

Role of MTDH, FOXM1 and microRNAs in Drug Resistance in Hepatocellular Carcinoma
by: Xiangbing Meng, et al.
Published: (2014-07-01)

LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c
by: Shuai Xue, et al.
Published: (2021-04-01)

SPOCK1 Promotes the Development of Hepatocellular Carcinoma
by: Lóránd Váncza, et al.
Published: (2022-02-01)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
by: Ning Zhang, et al.
Published: (2023-01-01)

Normalization of the ATP1A1 Signalosome Rescinds Epigenetic Modifications and Induces Cell Autophagy in Hepatocellular Carcinoma
by: Pradeep Kumar Rajan, et al.
Published: (2023-09-01)

Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma
by: Lóránd Váncza, et al.
Published: (2023-04-01)

Identification of <it>MACC1 </it>as a novel prognostic marker in hepatocellular carcinoma
by: Lu Canliang, et al.
Published: (2011-09-01)

Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
by: Tiffany Toni, et al.
Published: (2023-02-01)

Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma
by: Dirk Andreas Ridder, et al.
Published: (2021-02-01)

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
by: Chun-Ming Li, et al.
Published: (2023-03-01)

MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells
by: Binhui Xie, et al.
Published: (2020-09-01)

GSTZ1‐1 downregulates Wnt/β‐catenin signalling in hepatocellular carcinoma cells
by: Chong Lei, et al.
Published: (2020-01-01)

Low APOA-1 Expression in Hepatocellular Carcinoma Patients Is Associated With DNA Methylation and Poor Overall Survival
by: Yingyun Guo, et al.
Published: (2021-11-01)

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
by: James J. Harding, et al.
Published: (2021-05-01)

Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis
by: Bozkaya Giray, et al.
Published: (2012-09-01)

Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma
by: Yang LH, et al.
Published: (2018-04-01)

Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma
by: Sanghwa Kim, et al.
Published: (2021-04-01)

KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity
by: Kai Teng, et al.
Published: (2019-07-01)

Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma
by: Rok Razpotnik, et al.
Published: (2022-09-01)

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
by: Minjie Mao, et al.
Published: (2018-11-01)

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
by: Yunhao Chen, et al.
Published: (2019-08-01)

Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis
by: Xinghao Zhu, et al.
Published: (2021-01-01)

Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down‐regulation of c‐Met
by: Jia‐Jie Chen, et al.
Published: (2020-03-01)

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma
by: Abeer E. Awad, et al.
Published: (2019-07-01)